Praf2 is a novel Bcl-xL/Bcl-2 interacting protein with the ability to modulate survival of cancer cells

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Vento, Maria Teresa ^a   Zazzu, Valeria ^a,c   Loffreda, Alessia ^b   Cross, Justin R ^b,d   Downward, Julian ^a   Stoppelli, Maria Patrizia ^a   Iaccarino, Ingram ^a  

^a INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN PRAF2; UNCLASSIFIED DRUG; CARRIER PROTEIN; ETOPOSIDE; PRAF2 PROTEIN, HUMAN; PROTEIN BCL X;

APOPTOSIS; ARTICLE; CANCER CELL; CELL FRACTIONATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; GENE SILENCING; MITOCHONDRION; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; BIOLOGICAL MODEL; CELL LINE; CELL MEMBRANE POTENTIAL; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; MUTATION; NEOPLASM; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE;

APOPTOSIS; BCL-X PROTEIN; CARRIER PROTEINS; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; ETOPOSIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE POTENTIALS; MEMBRANE PROTEINS; MITOCHONDRIA; MODELS, BIOLOGICAL; MUTATION; NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 78650874294     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015636     Document Type: Article

References (56)

1. Iaccarino I, Hancock D, Evan G, Downward J (2003) C-Myc induces cytochrome c release in Rat1 fibroblasts by increasing outer mitochondrial membrane permeability in a Bid-dependent manner. Cell Death Differ 10: 599-608.
2. Dong Z, Wang J (2004) Hypoxia selection of death-resistant cells. A role for Bcl-X(L). J Biol Chem 279: 9215-9221.
3. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, et al. (1997) Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385: 544-548.
4. Amundson SA, Myers TG, Scudiero D, Kitada S, Reed JC, et al. (2000) An Informatics Approach Identifying Markers of Chemosensitivity in Human Cancer Cell Lines. Cancer Res 60: 6101-6110.
5. Youle RJ, Strasser A (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 9: 47-59.
6. Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, et al. (1999) Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol 144: 891-901.
7. Marani M, Tenev T, Hancock D, Downward J, Lemoine NR (2002) Identification of novel isoforms of the BH3 domain protein Bim which directly activate Bax to trigger apoptosis. Mol Cell Biol 22: 3577-3589.
8. Adams JM, Cory S (2007) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26: 1324-37.
9. Ferna'ndez Y, Espana L, Manas S, Fabra A, Sierra A (2000) Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance. Cell Death Differ 7: 350-9.
10. Du YN, Lewis BC, Hanahan D, Varmus H (2007) Assessing Tumor Progression Factors by Somatic Gene Transfer into a Mouse Model: Bcl-xL Promotes Islet Tumor Cell Invasion. PLoS Biology 5: e276 EP
11. Martin SS, Ridgeway AG, Pinkas J, Lu Y, Reginato MJ, et al. (2004) A cytoskeleton-based functional genetic screen identifies Bcl-xL as an enhancer of metastasis, but not primary tumor growth. Oncogene 23: 4641-5.
12. Vander Heiden MG, Choy JS, VanderWeele DJ, Brace JL, Harris MH, et al. (2002) Bcl-x(L) complements Saccharomyces cerevisiae genes that facilitate the switch from glycolytic to oxidative metabolism. J Biol Chem 277: 44870-6.
13. Li C, Fox CJ, Master SR, Bindokas VP, Chodosh LA, et al. (2002) Bcl-X(L) affects Ca(2+) homeostasis by altering expression of inositol 1,4,5-trisphosphate receptors. Proc Natl Acad Sci U S A 99: 9830-9835.
14. Li H, Chen Y, Jones AF, Sanger RH, Collis LP, et al. (2008) Bcl-xL induces Drp1-dependent synapse formation in cultured hippocampal neurons. Proc Natl Acad Sci U S A 105: 2169-2174.
15. O'Reilly LA, Huang DC, Strasser A (1996) The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J 15: 6979-90.
16. Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S, et al. (2004) Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol 6: 1221-1228.
17. Priault M, Hue E, Marhuenda F, Pilet P, Oliver L, et al. (2010) Differential dependence on Beclin 1 for the regulation of pro-survival autophagy by Bcl-2 and Bcl-xL in HCT116 colorectal cancer cells. PLoS ONE 5: e8755.
18. Berman SB, Chen Y, Qi B, McCaffery JM, Rucker EB, et al. (2009) Bcl-x L increases mitochondrial fission, fusion, and biomass in neurons. J Cell Biol 184: 707-719.
19. Vander Heiden MG, Li XX, Gottleib E, Hill RB, Thompson CB, et al. (2001) Bcl-xL promotes the open configuration of the voltage-dependent anion channel and metabolite passage through the outer mitochondrial membrane. J Biol Chem 276: 19414-19419.
20. Shimizu S, Narita M, Tsujimoto Y, Tsujimoto Y (1999) Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399: 483-487.
21. Rong Y, Bultynck G, Aromolaran AS, Zhong F, Parys JB, et al. (2009) The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor. Proc Natl Acad Sci U S A 106: 14397-14402.
22. Oberstein A, Jeffrey PD, Shi Y (2007) Crystal structure of the Bcl-XL-Beclin 1 peptide complex: Beclin 1 is a novel BH3-only protein. J Biol Chem 282: 13123-13132.
23. Hsu YT, Wolter KG, Youle RJ (1997) Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc Natl Acad Sci U S A 94: 3668-3672.
24. Jeong S, Gaume B, Lee Y, Hsu Y, Ryu S, et al. (2004) Bcl-x(L) sequesters its C-terminal membrane anchor in soluble, cytosolic homodimers. EMBO J 23: 2146-55.
25. Antonsson B, Montessuit S, Sanchez B, Martinou JC (2001) Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J Biol Chem 276: 11615-11623.
26. Ruggiero AM, Liu Y, Vidensky S, Maier S, Jung E, et al. (2008) The endoplasmic reticulum exit of glutamate transporter is regulated by the inducible mammalian Yip6b/GTRAP3-18 protein. J Biol Chem 283: 6175-6183.
27. Rigaut G, Shevchenko A, Rutz B, Wilm M, Mann M, et al. (1999) A generic protein purification method for protein complex characterization and proteome exploration. Nat Biotechnol 17: 1030-1032.
28. Martins LM, Iaccarino I, Tenev T, Gschmeissner S, Totty NF, et al. (2002) The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J Biol Chem 277: 439-444.
29. Cheng EHY, Sheiko TV, Fisher JK, Craigen WJ, Korsmeyer SJ (2003) VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science 301: 513-517.
30. Kuo TH, Kim HR, Zhu L, Yu Y, Lin HM, et al. (1998) Modulation of endoplasmic reticulum calcium pump by Bcl-2. Oncogene 17: 1903-1910.
31. Ha'jek P, Chomyn A, Attardi G (2007) Identification of a novel mitochondrial complex containing mitofusin 2 and stomatin-like protein 2. J Biol Chem 282: 5670-5681.
32. Li LY, Shih HM, Liu MY, Chen JY (2001) The cellular protein PRA1 modulates the anti-apoptotic activity of Epstein-Barr virus BHRF1, a homologue of Bcl-2, through direct interaction. J Biol Chem 276: 27354-27362.
33. Schweneker M, Bachmann AS, Moelling K (2005) JM4 is a four-transmembrane protein binding to the CCR5 receptor. FEBS Lett 579: 1751-1758.
34. Muchmore SW, Sattler M, Liang H, Meadows RP, Harlan JE, et al. (1996) X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381: 335-341.
35. Wang HG, Rapp UR, Reed JC (1996) Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87: 629-638.
36. Denis GV, Yu Q, Ma P, Deeds L, Faller DV, et al. (2003) Bcl-2, via its BH4 domain, blocks apoptotic signaling mediated by mitochondrial Ras. J Biol Chem 278: 5775-5785.
37. Minn AJ, Kettlun CS, Liang H, Kelekar A, Vander Heiden MG, et al. (1999) Bcl-xL regulates apoptosis by heterodimerization-dependent and -independent mechanisms. EMBO J 18: 632-643.
38. Geng J, Shin ME, Gilbert PM, Collins RN, Burd CG (2005) Saccharomyces cerevisiae Rab-GDI Displacement Factor Ortholog Yip3p Forms Distinct Complexes with the Ypt1 Rab GTPase and the Reticulon Rtn1p. Eukaryotic Cell 4: 1166-1174.
39. Cross JR, Postigo A, Blight K, Downward J (2008) Viral pro-survival proteins block separate stages in Bax activation but changes in mitochondrial ultrastructure still occur. Cell Death Differ 15: 997-1008.
40. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, et al. (2005) Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17: 393-403.
41. Willis SN, Chen L, Dewson G, Wei A, Naik E, et al. (2005) Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 19: 1294-1305.
42. Kelleher DJ, Gilmore R (1997) DAD1, the defender against apoptotic cell death, is a subunit of the mammalian oligosaccharyltransferase. Proc Natl Acad Sci U S A 94: 4994-4999.
43. Makishima T, Yoshimi M, Komiyama S, Hara N, Nishimoto T (2000) A subunit of the mammalian oligosaccharyltransferase, DAD1, interacts with Mcl-1, one of the bcl-2 protein family. J Biochem 128: 399-405.
44. Hauptmann P, Riel C, Kunz-Schughart LA, Fröhlich K, Madeo F, et al. (2006) Defects in N-glycosylation induce apoptosis in yeast. Mol Microbiol 59: 765-778.
45. Feral CC, Nishiya N, Fenczik CA, Stuhlmann H, Slepak M, et al. (2005) CD98hc (SLC3A2) mediates integrin signaling. Proc Natl Acad Sci U S A 102: 355-360.
46. Simpson CD, Mawji IA, Anyiwe K, Williams MA, Wang X, et al. (2009) Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation. Cancer Res 69: 2739-2747.
47. Edinger AL, Cinalli RM, Thompson CB (2003) Rab7 prevents growth factor-independent survival by inhibiting cell-autonomous nutrient transporter expression. Dev Cell 5: 571-582.
48. Abdul-Ghani M, Gougeon PY, Prosser DC, Da-Silva LF, Ngsee JK (2001) PRA isoforms are targeted to distinct membrane compartments. J Biol Chem 276: 6225-6233.
49. Sivars U, Aivazian D, Pfeffer SR (2003) Yip3 catalyses the dissociation of endosomal Rab-GDI complexes. Nature 425: 856-859.
50. Geerts D, Wallick CJ, Koomoa DT, Koster J, Versteeg R, et al. (2007) Expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in neuroblastoma: correlation with clinical features, cellular localization, and cerulenin-mediated apoptosis regulation. Clin. Cancer Res 13: 6312-6319.
51. Wang G, Shi X, Salisbury E, Timchenko NA (2008) Regulation of apoptotic and growth inhibitory activities of C/EBPalpha in different cell lines. Exp Cell Res 314: 1626-1639.
52. Kaufmann T, Schlipf S, Sanz J, Neubert K, Stein R, et al. (2003) Characterization of the signal that directs Bcl-x(L), but not Bcl-2, to the mitochondrial outer membrane. J Cell Biol 160: 53-64.
53. Fo CS, Coleman CS, Wallick CJ, Vine AL, Bachmann AS (2006) Genomic organization, expression profile, and characterization of the new protein PRA1 domain family, member 2 (PRAF2). Gene 371: 154-165.
54. Tagami S, Eguchi Y, Kinoshita M, Takeda M, Tsujimoto Y (2000) A novel protein, RTN-XS, interacts with both Bcl-XL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity. Oncogene 19: 5736-5746.
55. Wan Q, Kuang E, Dong W, Zhou S, Xu H, et al. (2007) Reticulon 3 mediates Bcl-2 accumulation in mitochondria in response to endoplasmic reticulum stress. Apoptosis 12: 319-328.
56. Zhu L, Xiang R, Dong W, Liu Y, Qi Y (2007) Anti-apoptotic activity of Bcl-2 is enhanced by its interaction with RTN3. Cell Biol Int 31: 825-830.